
President, The Center for Urologic Care
Member of the Healthcare Council
Guy Bernstein, MD, is the President and a practicing Urologist at the Center for Urologic Care in Bryn Mawr, Pennsylvania. Dr. Bernstein is experienced in all aspects of urology with special interest in erectile dysfunction, male infertility, incontinence, benign prostatic hypertrophy, prostatitis, and prostate cancer. He is certified in laparoscopic and laser surgery, cryosurgery and brachytherapy for prostate cancer, minimal invasive heat treatments for BPH, and sling procedures for male and female incontinence. Dr. Bernstein is the Vice-Chairman of the Main Line Hospitals Institutional Review Board, and has participated in clinical trials for GlaxoSmithKline, Ortho-McNeil, Novartis, Genomics, Sanofi-Synthelabo, Solvay, Myriad, Dendreon, and Pfizer. He is a member of the speaker's bureau for Ortho-McNeil, GlaxoSmithKline, Sanofi-Synthelabo, Lilly Icos, and Auxilium. Since 1988, Dr. Bernstein has served as an Attending Urologic Surgeon at Bryn Mawr Hospital. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
ED and cardiovascular disease are linked
August 11, 2006
Impotence could be sign of heart disease, study says | www.cnn.com
Erectile dysfunction may be the first indicator of serious cardiovasulcar disease which warrants evaluation and treatment.
Crowded Field of OAB Medications
August 11, 2006
Trospium Chloride Meets Primary and Secondary Endpoints in Phase 3 Trial | www.ptcommunity.com
Phase III trial of Sanctura XR shows efficacy in treatment of OAB with reduced side effect of dry mouth.
Guy Bernstein has not participated in any GLG Live Meetings.